Imagine being able to treat a disease in its earliest stages before symptoms even appear. Imagine being able to prevent the disease altogether. That’s the goal of precision medicine at Mercy. We’re committed to making this type of precision medicine not only possible but accessible to millions.
Knowing an individual’s genetic markers can help us know what to look for to prevent hereditary severe diseases. Studying precise genetic information allows Mercy to develop personalized treatment plans for our patients, which lead to better outcomes. For example, molecular testing can detect genetic variants in our cancer patients. These variants help physicians determine which treatments will improve survival as well as decrease side effects.
Precision medicine, or "personalized medicine," tailors disease prevention and treatment to each patient by considering genetics, environment and lifestyle. Knowledge of an individual patient at a molecular level helps us to anticipate and even prevent diseases.
Mercy provides genetic services and the latest genetic technology to help prevent, diagnose or treat a variety of health conditions, leading to better treatment outcomes and faster recoveries.
Precision medicine testing looks for genes, proteins, and other substances in the body and tailors treatments to those specific findings. Mercy’s collaborative care team includes a genetic counselor to interpret results and make sure the patient understands them and a navigator who guides the patient throughout their journey.
Through precision medicine, Mercy is not only able to pinpoint existing cancer in the body, but we can also identify increased risks of developing cancer so that patients can take preventive measures. Our advances in precision medicine also enable us to determine which treatments might be best for each individual patient.
Mercy is at the forefront of researching and implementing personalized medicine for a variety of diseases. Mercy’s advanced personalized testing and services include:
The Multi-Cancer Early Detection test can detect a shared signal across 50 types of cancer through a simple blood test. If a signal is detected, the results can help your healthcare provider guide the next steps.
Learn more & see if you’re eligible
Germline genetic testing looks for inherited gene changes (mutations) that can increase cancer risk. This testing can benefit adults of all ages who have an at-risk ethnicity or an immediate family history of cancer.
Mercy is committed to staying on the leading edge of developments in early detection, early treatment, and better outcomes for all patients entrusted to our care. We’re committed to improving our patients' health through biomarker testing, big data analytics, artificial intelligence, and pharmacogenomics.
Research into precision medicine is rapidly expanding our ability to develop diagnosis and treatment paths to benefit our patients at Mercy and worldwide.
At Mercy, a patient diagnosed with cancer no longer receives the exact same treatment as everyone else, thanks to an advanced understanding of how genetic differences can cause people to respond differently to the same treatment.
Precision medicine uses specific information about a person’s cancerous tumor to help make a detailed diagnosis and treatment plan, follow how treatment is working or make a prognosis. Examples of precision medicine include using tumor marker testing to help diagnose cancer and using targeted therapies and immunotherapies to treat specific types of cancer cells, such as HER2-positive breast cancer cells.
Genetic testing for cancer is used to see if someone has indicators that make them more likely to get specific cancer. types. But precision medicine can do more than tell if a patient is at higher risk for cancer. Mercy offers a new test that can screen for cancers already existing in the body. The Multi-Cancer Early Detection (MCED) test can detect cancers for which no current screenings exist. Mercy offers precision medicine that should be performed in addition to routine cancer screenings.
Using pharmacogenomics, a provider can determine which medications will be most successful in helping a specific patient. Pharmacogenomics uses information about an individual's molecular genome to enable providers to tailor drug prescriptions to each patient. The pharmacogenomic process will identify genetic variants that predict which patients may have an adverse reaction to a specific drug and which drugs will be most effective for each patient. Pharmacogenomics is commonly used for behavioral health medications and anticoagulation prescriptions.
Mercy has entered into a groundbreaking 10-year collaboration with Mayo Clinic. Because Mercy was an early adopter of Epic health information technology, we have the advantage of decades of deidentified patient outcomes to analyze. This allows us to discover patterns that signal when patients are at higher risk for specific health issues such as heart attack, stroke or disease.
This joint effort between Mercy and Mayo Clinic, using leading data science methods, will enable care providers around the world to diagnose diseases earlier and pursue proven treatment paths to start recoveries sooner.
At Mercy, we offer comprehensive services to diagnose and treat a full range of conditions, including:
At Mercy, we offer comprehensive testing services to diagnose conditions and injuries, including:
At Mercy, we offer compassionate care for a variety of treatment services, including: